Adenosine A1 receptors modulate anxiety in CD1 mice

Psychopharmacology

Volumn 136, Issue 4, 1998, Pages 311-319

  Florio, Chiara ^a   Prezioso, Anita ^a   Papaioannou, Aristotele ^a   Vertua, Rodolfo ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Adenosine A1 receptor; Anxiety Ex vivo binding; Light dark test; Plus maze

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR; ISOBUTYLMETHYLXANTHINE; 2 CHLORO N(6)CYCLOPENTYLADENOSINE; 2-CHLORO-N(6)CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE RECEPTOR; ANXIOLYTIC AGENT; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ANXIETY NEUROSIS; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; TRANQUILIZING ACTIVITY; ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; LIGHT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BRAIN; LIGHT; MALE; MAZE LEARNING; MICE; RECEPTORS, PURINERGIC P1;

EID: 0031596815     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050572     Document Type: Article

References (55)

1. Baldwin HA, Johnston AL, File SE (1989) Antagonistic effects of caffeine and yohimbine in animal tests of anxiety. Eur J Pharmacol 159:211-215
2. Barraco RA (1991) Behavioral actions of adenosine and related substances. In: Phillis JW (ed) Adenosine and adenine nucleotides as regulators of cellular function. CRC Press, Boca Raton, F1, pp 339-365
3. Baumgold J, Nikodijevic O, Jacobson KA (1992) Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol 43:889 894
4. Belzung C, Misslin R, Vogel E, Dodd RH, Chapouthier G (1987) Anxiogenic effects of methyl-β-carboline-3-carboxylate in a light/dark choice situation. Pharmacol Biochem Behav 28: 29 33
5. Bender AS, Phillis JW, Wu PH (1980) Diazepam and flurazepam inhibit adenosine uptake by rat brain synaptosomes. J Pharm Pharmacol 32:293 294
6. Bennett JP, Yamamura HI (1985) Neurotransmitter, hormone, or drug receptor binding models. In: Yamamura HI (ed) Neurotransmitter receptor binding. Raven Press, New York, pp 61 89
7. Blumstein LK, Crawley JN (1983) Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 18:37-40
8. Bruns RF, Katims JJ, Annau Z, Snyder SH, Daly JW (1983) Adenosine receptor interactions and anxiolytics. Neuropharmacology 22:1523 1529
9. 1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 335:59 63
10. Chopin P, Briley M (1993) The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze. Psychopharmacology 110:409 414
11. Coffin VL, Taylor JA, Phillis JW, Altman HJ, Barraco RA (1984) Behavioral interaction of adenosine and methylxanthines on central purinergic system. Neurosci Lett 47:91 98
12. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze: comparison with haloperidol. Psychopharmacology 114:288 296
13. Cole JC, Rodgers RJ (1995) Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol Biochem Behav 52:473 478
14. Commissaris RL, McCloskey TC, Damian GM, Brown BD, Barraco RA, Altman HJ (1990) Antagonism of the anti-conflict effects of phenobarbital, but not diazepam, by the A-1 adenosine agonist 1-PIA. Psychopharmacology 102:283 290
15. Crawley JN, Patel J, Marangos PJ (1981) Behavioral characterization of two long-lasting adenosine analogs: sedative properties and interaction with diazepam. Life Sci 29:2623 2630
16. Dawson GR, Trieklebank MD (1995) Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33 36
17. Florio C, Rosati AM, Traversa U, Vertua R (1994) Strain-related differences in adenosine receptor density and in behavioral sensitivity to adenosine analogs in mice. Pharmacol Biochem Behav 49:271 276
18. Florio C, Rosati AM, Traversa U, Vertua R (1997) Inhibitory and excitatory effects of adenosine antagonists on spontaneous locomotor activity in mice. Life Sci 60:1477 1486
19. Griebel G, Misslin R, Vogel E, Bourguignon JJ (1991a) Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors. Pharmacol Biochem Behav 39:321 323
20. 1-selective antagonist, DPCPX. Psychopharmacology 103: 541 544
21. Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113:463-470
22. Hamon M (1994) Neuropharmacology of anxiety: perspectives and prospects. Trends Pharmacol Sci 15:36 39
23. 2 receptors in the striatum of the rat following chronic treatment with diazepam. Neuropharmacology 27:1131-1140
24. Hooper N, Fraser C, Stone TW (1996) Effects of purine analogues on spontaneous alternation in mice. Psycopharmacology 123: 250 257
25. Imaizumi M, Miyazaki S, Onodera K (1994a) Effects of xanthine derivatives in a light/dark test in mice and the contribution of adenosine receptors. Meth Find Exp Clin Pharmacol 16: 639 644
26. Imaizumi M, Miyazaki S, Onodera K (1994b) Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20 1724, in a light/dark test in mice. Meth Find Exp Clin Pharmacol 16:717 721
27. Jain N, Kemp N, Adeyemo O, Buchanan P, Stone TW (1995) Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 116:2127 2133
28. Jarvis MF, Williams M (1988) Differences in adenosine A-1 and A-2 receptor density revealed by autoradiography in methylxanthine-sensitive and insensitive mice. Pharmacol Biochem Behav 30:707 714
29. 1 adenosine receptor binding in-vivo and ex-vivo. J Pharm Pharmacol 44:700 703
30. Katims JJ, Annau Z, Snyder SH (1983) Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J Pharmacol Exp Ther 227:167 173
31. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 340:679 683
32. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180 185
33. Logan L, Scale TW, Carney JM (1986) Inherent differences in sensitivity to methylxanthines among inbred mice. Pharmacol Biochem Behav 24:1281 1286
34. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 337:687 689
35. Moser PC (1993) Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced head-twitches by diazepam. Evidence for involvement of adenosine uptake inhibition. Drug Dev Res 30:213 218
36. Munson PJ, Rodbard D (1980) A versatile computerized approach for characterization of ligand-binding system. Anal Biochem 107:220 239
37. 2-selective adenosine agonists and antagonists: evidence for synergism and antagonism. J Pharmacol Exp Ther 259:286 294
38. 1 receptors in the nucleus accumbens impairs inhibitory avoidance memory. Behav Neural Biol 62:163 166
39. Palmer TM, Stiles GL (1995) Adenosine receptors. Neuropharmacology 34:683 694
40. Palmour RM, Lipowski CJ, Simon CK, Ervin FR (1989) Adenosine analogues inhibit lighting in isolated male mice. Life Sci 44:1293
41. Poon A, Sawynok J (1995) Antinoception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur J Pharmacol 286:177 184
42. Potier MC, Prado de Carvalho L, Venault P, Chapouthier G, Rossier J (1988) Demonstration of the partial agonist profiles of Ro 16 6028 and Ro 17 1812 in mice in vivo. Eur J Pharmacol 156:169 172
43. Ribeiro JA (1995) Purinergic inhibition of neurotransmitter release in the central nervous system. Pharmacol Toxicol 77:299 305
44. Seale TW, Abla KA, Cao W, Parker KM, Renner OM, Carney JM (1986) Inherent hyporesponsiveness to methylxanthine-induced behavioral changes associated withsupersensitivity to 5′-N-ethylcarboxamidoadenosine (NECA). Pharmacol Biochem Behav 25:1271-1277
45. Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 116:56 64
46. Simon P, Panissaud C, Costentin J (1994) The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. Psychopharmacology 114:597-600
47. 1 receptors in the rat brain in the kindling model of epilepsy. Eur J Pharmacol 265:121-124
48. Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, Woodruff GN (1996) The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127: 1 9
49. Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78:3260-3264
50. Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs. Springer, New York
51. Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469
52. Wachtel H, Loschmann PA (1986) Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram. Psychopharmacology 90:430-435
53. Wieland S, Belluzzi JD, Stein L, Lan NC (1995) Comparative behavioral characterization of the neuroactive steroids 3α-OH.5α-pregnan-20-one and 3α-OH.5β-pregnan-20-one in rodents. Psychopharmacology 118:65-71
54. Zangrossi H, Leite JR, Graeff FG (1992) Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine. Psychopharmacology 106:85-89
55. 1 receptors underlies anticonvulsant effect of CGS21680. Eur J Pharmacol 255:239 243